CA 27.29 Cancer Antigen

Description: For the quantitative determination of CA 27.29 antigen in serum of patients previously treated for stage II or stage III breast cancer. Serial testing for CA 27.29 antigen in patients who are clinically free of disease should be used in conjunction with other clinical methods for the early detection of recurrence.

Includes: Cancer Antigen (CA) 27.29

L452SST